Methenamine Hippurate

CHEMBL1201104 Phase 4 ได้รับการอนุมัติ Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

319.4 g/mol

LogP

—

Phase

4

A hippurate salt form of methenamine used to prevent recurrent urinary tract infections by releasing antibacterial formaldehyde in the bladder.

น้ำหนักโมเลกุล

319.3600 g/mol

TPSA

79.40 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure

Embed this structure

SMILES

C1N2CN3CN1CN(C2)C3.O=C(O)CNC(=O)c1ccccc1

InChI

InChI=1S/C9H9NO3.C6H12N4/c11-8(12)6-10-9(13)7-4-2-1-3-5-7;1-7-2-9-4-8(1)5-10(3-7)6-9/h1-5H,6H2,(H,10,13)(H,11,12);1-6H2

Molecular Formula

C15H21N5O3

HBD / HBA

2 / 7

พันธะที่หมุนได้

3

อะตอมหนัก

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

A hippurate salt form of methenamine used to prevent recurrent urinary tract infections by releasing antibacterial formaldehyde in the bladder.

Yes, Methenamine Hippurate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201104. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 21945. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

กำลังมองหาข้อมูลที่เข้าใจง่ายสำหรับผู้ป่วยอยู่ใช่ไหม?

Methenamine Hippurate บน PillFYI

โครงสร้าง

ข้อมูลด่วน

สูตร: C15H21N5O3
คำพ้องความหมาย: 1

ลิงก์ภายนอก

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.